The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Oct 2020
Historique:
received: 25 08 2020
revised: 16 10 2020
accepted: 21 10 2020
entrez: 31 10 2020
pubmed: 1 11 2020
medline: 30 3 2021
Statut: epublish

Résumé

The human leukocyte antigen (HLA)-Ib molecule, HLA-F, is known as a CD4

Identifiants

pubmed: 33126487
pii: ijms21218012
doi: 10.3390/ijms21218012
pmc: PMC7672607
pii:
doi:

Substances chimiques

HLA-F antigens 0
Hemoglobins 0
Histocompatibility Antigens Class I 0
KIR3DS1 protein, human 0
Peptide Fragments 0
Proteome 0
Receptors, KIR3DS1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Hector foundation
ID : MED1912

Références

Hum Immunol. 2018 Jun;79(6):453-462
pubmed: 29605689
Adv Immunol. 2015;127:33-144
pubmed: 26073983
Immunogenetics. 2018 Aug;70(8):485-494
pubmed: 29602958
Immunity. 1999 Jun;10(6):661-71
pubmed: 10403641
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
J Virol. 2019 Aug 28;93(18):
pubmed: 31270222
J Virol. 2007 Jan;81(2):474-82
pubmed: 17079298
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Bone Marrow Transplant. 2004 Jan;33(2):165-9
pubmed: 14647261
ISRN AIDS. 2013 Aug 12;2013:954806
pubmed: 24052891
Eur J Immunol. 2010 Aug;40(8):2308-18
pubmed: 20865824
Int J Inflam. 2014;2014:803237
pubmed: 25431740
Eur J Immunol. 2000 Dec;30(12):3552-61
pubmed: 11169396
Science. 2000 Feb 11;287(5455):1031
pubmed: 10669413
J Immunol. 2013 Oct 1;191(7):3553-62
pubmed: 24018270
Front Immunol. 2012 Nov 01;3:326
pubmed: 23125843
Stem Cells Int. 2015;2015:346714
pubmed: 26366178
Immunity. 2017 Jun 20;46(6):1018-1029.e7
pubmed: 28636952
Int J Mol Sci. 2019 Nov 08;20(22):
pubmed: 31717259
Curr Opin Immunol. 2011 Feb;23(1):104-10
pubmed: 20970974
Nat Microbiol. 2019 Nov;4(11):1872-1884
pubmed: 30988430
AAPS J. 2010 Dec;12(4):658-69
pubmed: 20811967
Cell Rep. 2019 Nov 12;29(7):1923-1933.e3
pubmed: 31722207
Science. 2016 Oct 21;354(6310):354-358
pubmed: 27846572
Antivir Ther. 2005;10(1):95-107
pubmed: 15751767
Nature. 1960 Feb 13;185(4711):416-22
pubmed: 18990801
Nat Commun. 2018 Mar 12;9(1):1026
pubmed: 29531227
Am J Pathol. 2005 Feb;166(2):443-53
pubmed: 15681828
Front Cell Infect Microbiol. 2017 Nov 08;7:461
pubmed: 29167762
Tissue Antigens. 2012 Sep;80(3):239-48
pubmed: 22803829
Int J Mol Sci. 2019 Jul 24;20(15):
pubmed: 31344940
Nat Immunol. 2016 Sep;17(9):1067-74
pubmed: 27455421
Nat Immunol. 2015 Nov;16(11):1153-61
pubmed: 26437244
J Immunol. 2010 Jun 1;184(11):6199-208
pubmed: 20483783
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909402
J Proteomics. 2015 Oct 14;128:469-75
pubmed: 26141508
Neuropathol Appl Neurobiol. 2003 Jun;29(3):273-9
pubmed: 12787324
Immunogenetics. 2016 Jan;68(1):29-41
pubmed: 26552660
Clin Proteomics. 2019 May 8;16:19
pubmed: 31080378
Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S108-S123
pubmed: 28223351
Immunogenetics. 2019 May;71(5-6):353-360
pubmed: 30941482
J Immunol. 2000 Jan 1;164(1):319-28
pubmed: 10605026

Auteurs

Gia-Gia T Hò (GT)

Institute for Transfusion Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Wiebke Hiemisch (W)

Institute for Transfusion Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Andreas Pich (A)

Institute of Toxicology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Georg M N Behrens (GMN)

Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
German Center for Infections Research, partner site Hannover-Braunschweig, Inhoffenstraße 7, 38124 Braunschweig, Germany.

Rainer Blasczyk (R)

Institute for Transfusion Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Christina Bade-Doeding (C)

Institute for Transfusion Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH